Healthy food choices found to be key in reducing heart disease risk
A new study that followed almost 200,000 people for several decades has found that when it comes to heart health, the quality of food consumed matters as much as following…
A new study that followed almost 200,000 people for several decades has found that when it comes to heart health, the quality of food consumed matters as much as following…
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had…
While moms have traditionally gotten much of the focus when it comes to children's eating habits, a new study highlights the importance of dads in shaping a child's relationship with…
Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to survive hundreds of years by adjusting its virulence and the…
Tobacco-funded research is still appearing in highly-cited medical journals - despite attempts by some to cut ties altogether, finds an investigation by The Investigative Desk and The BMJ today.
Macrophages and other immune cells are the natural frontline immune warriors of our body, defending the body against invading pathogens and cancer cells.
A new device that monitors the waste-removal system of the brain may help to prevent Alzheimer's and other neurological diseases, according to a study published today in Nature Biomedical Engineering.
Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of Malignant Pleural Mesothelioma (MPM), a rare and aggressive cancer.
As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics – demonstrating exactly how each result…
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by…